KOMET-007 Trial in Progress: A Phase I Study of Ziftomenib in Combination with Venetoclax or Venetoclax/ Azacitidine, or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination with Ziftomenib, for the Treatment of Patients with Acute Myeloid Leukemia
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
acute myeloid leukemia (AML),menin inhibitor,clinical trial,trial-in-progress
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要